\n Singapore is the latest in DHL Global Forwarding Asia Pacific\u2019s network to once again be recognized by IATA for the highest standards met by logistics providers for life science and healthcare (LSH) shipments <\/p>\n
SINGAPORE –\u00a0Media
DHL
\u00a0<\/p>\n
The
\u00a0<\/p>\n
“As
\u00a0<\/p>\n
\u00a0DHL has been actively involved with IATA’s
\u00a0<\/p>\n
“As
\u00a0<\/p>\n
Following
\u00a0<\/p>\n
DHL
\u00a0<\/p>\n
With
\u00a0<\/b><\/p>\n
Note to editors:<\/i><\/b><\/p>\n
Vaccine logistics for Covid-19 will pose challenges along
\nOutReach<\/a>\u00a0–\u00a09 February 2021 –\u00a0As the furor around
\nthe availability of Covid-19 vaccines grew late last year, the spotlight
\nquickly turned to the logistics sector and its capabilities in delivering more
\nthan ten billion doses<\/a> under stringent
\ntemperature requirements worldwide. Concerns are well-founded, as the
\nbio-pharmaceutical sector reportedly suffers from an estimated USD35
\nbillion loss annually<\/a>
\npre-Covid due to failures in temperature-controlled logistics.<\/p>\n![](\"https:\/\/release.media-outreach.com\/release.php\/Images\/Thumb\/500x0\/123690\/DHL-Pharma-shipment.jpg#image-123690\")
<\/p>\n
\n
<\/p>\n
\nGlobal Forwarding, the air, ocean and road freight specialist of Deutsche Post
\nDHL Group, began certifying its global stations with the IATA CEIV Pharma
\nStandard since 2016 and has recently re-certified its air freight station in
\nSingapore for another year. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nIATA CEIV Pharma
\nStandard<\/a>,
\nrun by International Air Transport Association (IATA), is designed to ensure
\ncompliance, standardization, accountability and transparency across the air
\ntransport supply chain. “Singapore is the latest in our Asia Pacific network,
\nalong with Japan and China, to receive the IATA CEIV Pharma re-certification.
\nThis is especially timely as several countries try to secure Covid-19 vaccines
\nto put a halt to the economic and social impact of the pandemic,” said Kelvin
\nLeung, CEO, DHL Global Forwarding Asia Pacific. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nour teams continue to work closely with our customers to deliver these
\nvaccines, we appreciate that the accreditation is not only a quality mark of
\nour service and network, but is equally a recognition of the hard work and
\ndedication of our LSH specialists who work seamlessly across the world to
\ndeliver best-in-class logistics services to our customers,” he added. \u00a0<\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\ncontinuous efforts to adequately answer to the regulatory demands of the
\npharmaceutical industry. At each location, IATA examines and compares the
\nstation’s correspondence to its Temperature Control Regulations (TCR) as well
\nas GDP (Good Distribution Practices) guidelines from the European Union, World
\nHealth Organization and other regulatory bodies. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nthe freight forwarder that was involved with bringing in Singapore’s first batch<\/a> of Covid-19
\nvaccines, DHL Global Forwarding places a huge emphasis on delivering the
\nhighest supply chain standards for our LSH customers. The re-certification of
\nthe IATA CEIV Pharma on a corporate level and for our air freight station at
\nChangi Airport stands testament to our commitment to support governments and
\nthe LSH sector during this crucial recovery period,” said Christopher Lim,
\nManaging Director, DHL Global Forwarding Singapore and Malaysia. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nindependent audits by third parties and training courses for employees on site,
\nthe DHL Air GxP (good practice) facility in Singapore successfully renewed the
\nquality label by exceeding the usual quality standards for transportation and
\nstorage of pharmaceutical goods. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nprovides its worldwide employees with vital tools to understand and meet customers’
\nand regulatory expectations. In addition to implementing specialized training
\nprogram by IATA regulation standards across its key GxP (good practice) facilities,
\nDHL’s CIF Certified Life Sciences Specialist (CLSS) program equally provides
\na\u00a0comprehensive curriculum of mandatory trainings, functional courses, and
\nmaterial to unlock the knowledge of this specialized industry. Like at all
\ntemperature-controlled locations of DHL, every designated employee in Singapore
\ninvolved in such shipments have successfully completed the training and are
\ncertified LSH Specialists. This ensures that sensitive shipments are handled
\nwith utmost care and in compliance with the highest industry standards. <\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nits international network, DHL offers a wide-ranging product portfolio at its Air
\nGxP locations that covers all client needs for time and temperature sensitive airfreight
\nshipments and provides seamless temperature visibility along the supply chain.
\nThrough its excellent service, DHL has successfully established itself as the
\nmarket leader for logistics solutions in the LSH industry. Special services
\nalso include the door-to-door courier solution “Life Sciences graded Specialty
\nCourier”, the express service “Medical Express” with a fixed delivery time, and
\n“DHL Clinical Trial Logistics”, a logistics solution designed for clinical
\nstudies such as the transportation of trial medication, ancillaries, and lab
\nkits. \u00a0<\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\n
<\/p>\n
\nthe supply chain that must be jointly addressed by governments, NGOs,
\npharmaceutical companies, and logistics players urgently. <\/i>Find out<\/i><\/a> what lessons Covid-19 has taught on securing stable
\nsupply chains for future emergencies and the complexities in distributing the
\nvaccine across the globe.<\/i><\/p>\n